CymaBay Therapeutics, Inc.

CBAY · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$206,535$20,291$125,806$28,193
Short-Term Investments$187,720$115,194$60,729$118,130
Receivables$0$0$0$277
Inventory$0$0$0$0
Other Curr. Assets$9,547$2,588$4,564$4,985
Total Curr. Assets$403,802$138,073$191,099$151,585
Property Plant & Equip (Net)$5,725$870$1,432$2,033
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$22,360$0$8,067$0
Tax Assets$0$0$0$0
Other NC Assets$2,799$2,909$1,720$207
Total NC Assets$30,884$3,779$11,219$2,240
Other Assets$0$0$0$0
Total Assets$434,686$141,852$202,318$153,825
Liabilities
Payables$3,828$1,096$2,728$231
Short-Term Debt$10,007$664$567$482
Tax Payable$0$0$0$0
Deferred Revenue$1,689$0$0$0
Other Curr. Liab.$21,319$13,681$15,071$9,144
Total Curr. Liab.$36,843$15,441$18,366$9,857
LT Debt$104,487$90,257$51,015$1,262
Deferred Rev, NC$1,100$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$105,587$90,257$51,015$1,262
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$142,430$105,698$69,381$11,119
Equity
Pref Stock$0$0$0$0
Common Stock$11$8$8$7
Retained Earnings-$978,227-$872,857-$766,856-$676,858
AOCI$144-$326-$13$8
Other Equity$1,270,328$909,329$899,798$819,549
Total Equity$292,256$36,154$132,937$142,706
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$434,686$141,852$202,318$153,825
Net Debt-$92,041$70,630-$74,224-$26,449